Synopsis : The US FDA announced plans to update the safety label for paracetamol to reflect studies suggesting a possible association between prenatal use and neurodevelopmental conditions. Research has suggested a potential link between acetaminophen use during pregnancy and an increased risk of neurodevelopmental disorders, but scientists caution that a direct cause-and-effect relationship has not been established.

The United States Food and Drug Administration (FDA) announced plans to update the safety label for acetaminophen (commonly known as paracetamol or Tylenol) to reflect studies suggesting a possible association between prenatal use and neurodevelopmental conditions, including autism and ADHD.

The move has drawn public attention after US President Donald Trump urged pregnant

See Full Page